Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Arrhythmias

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 75 articles: HTML format

Single Articles

February 2026
1. SCHWARTZ PJ, Crotti L
   Long QT Syndrome. Reply.
   N Engl J Med. 2026;394:826-827.
   PubMed    
   
   
   
2. BIBAS M, Moschella Orsini F, Mazzotta V
   Long QT Syndrome.
   N Engl J Med. 2026;394:826.
   PubMed    
   
   
   
3. BUNDGAARD H, Zheng C, Jons C
   Potassium Levels and Risk of Ventricular Arrhythmias. Reply.
   N Engl J Med. 2026;394:725-726.
   PubMed    
   
   
   
4. INGWILLER M
   Potassium Levels and Risk of Ventricular Arrhythmias.
   N Engl J Med. 2026;394:725.
   PubMed    
   
   
   
5. YUAN Y, Tang Y, Wu Y
   Potassium Levels and Risk of Ventricular Arrhythmias.
   N Engl J Med. 2026;394:725.
   PubMed    
   
   
   
6. ABRAMOV D, Garg J
   Potassium Levels and Risk of Ventricular Arrhythmias.
   N Engl J Med. 2026;394:724-725.
   PubMed    
   
   
   
7. HURTADO-TORRES GF
   Potassium Levels and Risk of Ventricular Arrhythmias.
   N Engl J Med. 2026;394:724.
   PubMed    
   
   
   
8. RIVERA RF, Sciarrone Alibrandi MT
   Potassium Levels and Risk of Ventricular Arrhythmias.
   N Engl J Med. 2026;394:723-724.
   PubMed    
   
   
   
9. LIP GYH, Kuzma L
   Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents.
   N Engl J Med. 2026;394:713-715.
   PubMed    
   
   
   January 2026
10. CHELU MG, Poole JE, Ellenbogen KA
    Physiologic Pacing in Heart Failure.
    N Engl J Med. 2026;394:367-381.
    PubMed     Abstract available
    
    
    
11. ALBERT CM
    Anticoagulation after Ablation for Atrial Fibrillation - Navigating the OCEAN of Possibilities.
    N Engl J Med. 2026;394:393-394.
    PubMed    
    
    
    
12. LAMPERT R, Harmon KG
    Sudden Cardiac Arrest in Athletes.
    N Engl J Med. 2026;394:268-280.
    PubMed     Abstract available
    
    
    November 2025
13. CHATTERJEE NA
    Targeting Potassium for Prevention of Ventricular Arrhythmias.
    N Engl J Med. 2025;393:2047-2048.
    PubMed    
    
    
    
14. SCHWARTZ PJ, Crotti L
    Long QT Syndrome.
    N Engl J Med. 2025;393:2023-2034.
    PubMed    
    
    
    
15. VERMA A, Birnie DH, Jiang C, Heidbuchel H, et al
    Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation.
    N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2509688.
    PubMed     Abstract available
    
    
    
16. LEE SJ, Yu HT, Lee YJ, Lee SH, et al
    Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents.
    N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2512091.
    PubMed     Abstract available
    
    
    August 2025
17. MUNKHAUGEN J, Kristensen AMD, Halvorsen S, Holmager T, et al
    Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2505985.
    PubMed     Abstract available
    
    
    
18. JONS C, Zheng C, Winslow UCG, Danielsen EM, et al
    Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias.
    N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2509542.
    PubMed     Abstract available
    
    
    July 2025
19. REICHLIN T, Juni P, Sticherling C
    Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation. Reply.
    N Engl J Med. 2025;393:519-520.
    PubMed    
    
    
    
20. CHEN M, Li X, Zhou S
    Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2025;393:519.
    PubMed    
    
    
    
21. KARAKASIS P, Fragakis N
    Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2025;393:518-519.
    PubMed    
    
    
    
22. BLACKWELL JN, Wang NC, Bhonsale A
    Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2025;393:518.
    PubMed    
    
    
    
23. MCFARLAND R, Hyslop LA, Feeney C, Pillai RN, et al
    Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease.
    N Engl J Med. 2025;393:461-468.
    PubMed     Abstract available
    
    
    
24. WAZNI OM, Roy K
    Atrial Appendage Closure after Ablation for Atrial Fibrillation. Reply.
    N Engl J Med. 2025;393:202-203.
    PubMed    
    
    
    
25. LEON-ACUNA IG
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:202.
    PubMed    
    
    
    
26. PIMENTEL M
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:201-202.
    PubMed    
    
    
    
27. OCCHIPINTI G, Brugaletta S, Sabate M
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:201.
    PubMed    
    
    
    
28. BYUN JH
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:201.
    PubMed    
    
    
    
29. TAM MTK, Chan JYS, So KCY
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:200-201.
    PubMed    
    
    
    May 2025
30. GOREY S, Healey JS, Kirchhof P
    Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation.
    N Engl J Med. 2025;392:1749-1751.
    PubMed    
    
    
    April 2025
31. RUFF CT, Goodrich EL, Sabatine MS
    Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. Reply.
    N Engl J Med. 2025;392:1557.
    PubMed    
    
    
    
32. RASCHI E, Squizzato A
    Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:1556-1557.
    PubMed    
    
    
    
33. HENRY C
    Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:1556.
    PubMed    
    
    
    March 2025
34. REICHLIN T, Kueffer T, Badertscher P, Juni P, et al
    Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2502280.
    PubMed     Abstract available
    
    
    
35. PICCINI JP, Patel MR, Caso V
    Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply.
    N Engl J Med. 2025;392:1247-1248.
    PubMed    
    
    
    
36. BENKHOFF M, Mourikis P, Polzin A
    Asundexian versus Apixaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:1247.
    PubMed    
    
    
    
37. STRAW S, Witte KK, Philippou H
    Asundexian versus Apixaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:1246-1247.
    PubMed    
    
    
    February 2025
38. CHO MS, Nam GB, Park DW
    Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease. Reply.
    N Engl J Med. 2025;392:826-827.
    PubMed    
    
    
    
39. SHIMAZU Y
    Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2025;392:826.
    PubMed    
    
    
    
40. GREMMEL T
    Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2025;392:826.
    PubMed    
    
    
    January 2025
41. RUFF CT, Patel SM, Giugliano RP, Morrow DA, et al
    Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:361-371.
    PubMed     Abstract available
    
    
    November 2024
42. WAZNI OM, Saliba WI, Nair DG, Marijon E, et al
    Left Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2408308.
    PubMed     Abstract available
    
    
    
43. SAPP JL, Tang ASL, Parkash R, Stevenson WG, et al
    Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2409501.
    PubMed     Abstract available
    
    
    
44. RUBIN EJ, Leopold J, Morrissey S
    NEJM at AHA - Left Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMe2414475.
    PubMed    
    
    
    
45. RUBIN EJ, Leopold J, Morrissey S
    NEJM at AHA - Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMe2414471.
    PubMed    
    
    
    October 2024
46. KNOPS RE, Lloyd MS, Roberts PR, Wright DJ, et al
    A Modular Communicative Leadless Pacing-Defibrillator System.
    N Engl J Med. 2024;391:1402-1412.
    PubMed     Abstract available
    
    
    September 2024
47. RUBIN EJ, Leopold J, Morrissey S
    NEJM at ESC - Asundexian versus Apixaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2410902.
    PubMed    
    
    
    
48. RUBIN EJ, Leopold J, Morrissey S
    NEJM at ESC - Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2410903.
    PubMed    
    
    
    
49. LIP GYH
    Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2409696.
    PubMed    
    
    
    
50. PICCINI JP, Patel MR, Steffel J, Ferdinand K, et al
    Asundexian versus Apixaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMoa2407105.
    PubMed     Abstract available
    
    
    
51. CHO MS, Kang DY, Ahn JM, Yun SC, et al
    Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMoa2407362.
    PubMed     Abstract available
    
    
    May 2024
52. CONNOLLY SJ, Sharma M, Cohen AT, Demchuk AM, et al
    Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.
    N Engl J Med. 2024;390:1745-1755.
    PubMed     Abstract available
    
    
    April 2024
53. KUROLAP A, Chai Gadot C, Baris Feldman H
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis. Reply.
    N Engl J Med. 2024;390:1539-1540.
    PubMed    
    
    
    
54. ABASSI Z, Azzam ZS, Heyman SN
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1539.
    PubMed    
    
    
    
55. GLADYSHEVA IP, Wang D, Reed GL
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1538-1539.
    PubMed    
    
    
    
56. DOMINY J, Koch C, Lamarche L, Denning D, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1537-1538.
    PubMed    
    
    
    
57. HEALEY JS, Lopes RD
    Stroke Prevention in Subclinical Atrial Fibrillation. Reply.
    N Engl J Med. 2024;390:1442.
    PubMed    
    
    
    
58. ALLEN AL, Kibert J 2nd, Wall TS
    Stroke Prevention in Subclinical Atrial Fibrillation.
    N Engl J Med. 2024;390:1441-1442.
    PubMed    
    
    
    
59. LEE TC, Kaul S, Mandrola J
    Stroke Prevention in Subclinical Atrial Fibrillation.
    N Engl J Med. 2024;390:1441.
    PubMed    
    
    
    
60. LI S, Lip GYH, Ko D, Walkey A, et al
    Anticoagulation for Secondary Atrial Fibrillation.
    N Engl J Med. 2024;390:1237-1240.
    PubMed    
    
    
    March 2024
61. BUNCH TJ
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation. Reply.
    N Engl J Med. 2024;390:1056.
    PubMed    
    
    
    
62. REDDY VY, Gerstenfeld EP, Mansour M
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation. Reply.
    N Engl J Med. 2024;390:1055-1056.
    PubMed    
    
    
    
63. WOODS C, Schricker A, Hao S
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2024;390:1055.
    PubMed    
    
    
    
64. FRANCESCHI F, Maille B
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2024;390:1054-1055.
    PubMed    
    
    
    
65. DHAWAN R, Bikmal A
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2024;390:1054.
    PubMed    
    
    
    December 2023
66. SOHNS C, Tijssen JGP, Sommer P
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. Reply.
    N Engl J Med. 2023;389:2496-2497.
    PubMed    
    
    
    
67. KERLEY RN, Joyce E
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
    N Engl J Med. 2023;389:2495-2496.
    PubMed    
    
    
    
68. BLACKWELL JN, Olshansky B, Estes NAM 3rd
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
    N Engl J Med. 2023;389:2495.
    PubMed    
    
    
    November 2023
69. HEALEY JS, Lopes RD, Granger CB, Alings M, et al
    Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
    N Engl J Med. 2023 Nov 12. doi: 10.1056/NEJMoa2310234.
    PubMed     Abstract available
    
    
    
70. SVENNBERG E
    What Lies beneath the Surface - Treatment of Subclinical Atrial Fibrillation.
    N Engl J Med. 2023 Nov 12. doi: 10.1056/NEJMe2311558.
    PubMed    
    
    
    
71. BUNCH TJ
    Hope, Hype, and Reality of Pulsed Field Ablation for Atrial Fibrillation.
    N Engl J Med. 2023;389:1720-1721.
    PubMed    
    
    
    
72. BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2023;389:1685-1692.
    PubMed     Abstract available
    
    
    October 2023
73. LEWIS EF
    Catheter Ablation for Atrial Fibrillation in Heart Failure - An Option to Defer Transplantation?
    N Engl J Med. 2023;389:1429-1430.
    PubMed    
    
    
    September 2023
74. STONE PH, Sauer WH
    Harnessing the Deluge of Rhythm-Monitoring Data for the Prevention of Stroke.
    N Engl J Med. 2023;389:1232-1234.
    PubMed    
    
    
    August 2023
75. KIRCHHOF P, Toennis T, Goette A, Camm AJ, et al
    Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.
    N Engl J Med. 2023 Aug 25. doi: 10.1056/NEJMoa2303062.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum